We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
US-based healthcare company Collidion has entered a definitive agreement to purchase 80% equity stake in the early stage biotechnology company Plex Pharmaceuticals for an undisclosed amount.